Code  Description Qty  Each  Total  TT-MS-s Trial TRAX Multiple Sclerosis - Single User Report: Trial TRAX-Multiple Sclerosis (October 2007) Clinical Intelligence Monitoring Brief provides analysis of ongoing clinical studies for competitors within the Multiple Sclerosis therapeutic area. Single User. $1,000.00 $1,000.00  TCI-MS-g TCI Multiple Sclerosis - Global License Report: Therapeutic Clinical Intelligence-Multiple Sclerosis (April 2007) Detailed assessment of the clinical profiles of currently marketed drugs, and the orally formulated compounds & novel biologics in development for MS. Group license. $9,000.00 $9,000.00  TCI-T2D-s TCI Type 2 Diabetes Pipelline - Single User Report: Therapeutic Clinical Intelligence-Type 2 Diabetes Pipeline (June 2008) Report profiles the 35 most promising compounds in mid-to-late stage development for the treatment of Type-2 Diabetes. Single User $4,500.00 $4,500.00  TT-MS-g Trial TRAX Multiple Sclerosis - Group License Report: Trial TRAX-Multiple Sclerosis (October 2007) Clinical Intelligence Monitoring Brief provides analysis of ongoing clinical studies for competitors within the Multiple Sclerosis therapeutic area. Group License. $2,000.00 $2,000.00  TCI-P-g TCI Psoriasis - Group License Report: Therapeutic Clinical Intelligence-Psoriasis (August 2007) Report provides detailed information & analysis of the clinical data on key marketed & pipeline competitors in Psoriasis therapeutics market. Group license. $1,500.00 $1,500.00  TT-A-s Trial TRAX Alzheimer's - Single User Report: Trial TRAX-Alzheimer's (September 2007) Report provides detailed information & analysis of the clinical data on key marketed & pipeline competitors in Alzheimer therapeutics market. Single user. $700.00 $700.00 Subtotal: $18,700.00

©2007 Austin Research Group